Newsletter

Health Network》Read the Q&A on anti-lactation drugs at once!Food and Drug Administration: Will not make breasts smaller – Free Health Network

The Food and Drug Administration pointed out that cabergoline, a commonly used anti-milk agent today, does not pose a risk of cancer and will not affect the appearance or shrinkage of the breasts; the picture shows the situation. (Picture taken from freepik)

Lin Huiqin/Review Editor

[Health Channel/Comprehensive Report]Some women need to stop breastfeeding due to various reasons after giving birth, so they use anti-lactogenic drugs. Many people are curious, will there be any side effects? The Food and Drug Administration posted an article on the Facebook fan page “Dr. Doctors Say True Medicine” explaining that today’s commonly used breast-feeding drugs do not pose a risk of cancer and will not affect the appearance or shrinkage of breasts, but they may cause headaches, dizziness, nausea, and abdominal pain. and other side effects, and is not recommended for people with poorly controlled hypertension.

3 common doubts

●Will anti-lactation drugs cause breast reduction or sagging?

No, anti-milk medication will not affect the appearance of your breasts. The main reason for breast reduction or sagging is that the breast milk originally filled with breast milk subsides and will naturally return to the size before breastfeeding. The breast tissue after breastfeeding will also be softer. Even natural breast reduction will have the same phenomenon.

●Can anti-lactation drugs cause cancer?

Won’t. The currently common breast-reducing drug (Cabergoline) does not pose a risk of cancer. Although estrogen alone or plus androgen were used as anti-galactogenic drugs in the early days, they are now rarely used and there is no need to worry too much about short-term use.

●What are the side effects of anti-lactation medicine?

The currently commonly used anti-lactation drug Cabergoline may have side effects including headache, dizziness, nausea, and abdominal pain. Side effects may continue for several days after the medication is stopped. In addition, cabergoline is not recommended for use in people with poorly controlled hypertension.

The Food and Drug Administration reminds that whether and how to withdraw breast milk is an important decision for postpartum women. It is recommended to consult a medical professional first to learn more about various methods of withdrawing breast milk.

☆Don’t miss out on health news, like and follow the fan page.

☆For more important medical news, please visit the Free Health Network.

No need to draw, no need to grab. Now use the APP to read the news, guaranteed to win every day. Click me to download the APP. Click me to see the event instructions.